⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Study Evaluating Two Dose Levels of Targretin Capsules in Participants With Refractory Cutaneous T-Cell Lymphoma (CTCL)

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Study Evaluating Two Dose Levels of Targretin Capsules in Participants With Refractory Cutaneous T-Cell Lymphoma (CTCL)

Official Title: Phase IV Randomized Study of Two Dose Levels of Targretin® Capsules in Subjects With Refractory Cutaneous T-Cell Lymphoma

Study ID: NCT01007448

Interventions

Bexarotene

Study Description

Brief Summary: This is a multicenter, randomized, open-label, Phase IV study to assess the efficacy, tolerability, and safety of 2 initial dose levels of bexarotene capsules in participants with refractory CTCL.

Detailed Description:

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

University of Alabama at Birmingham, Birmingham, Alabama, United States

Florida Academic Dermatology Centers, Miami, Florida, United States

Emory University, Atlanta, Georgia, United States

Rush University, Chicago, Illinois, United States

Tulane, New Orleans, Louisiana, United States

University of Michigan, Ann Arbor, Michigan, United States

University of Minnesota Medical School, Minneapolis, Minnesota, United States

Washington University, Saint Louis, Missouri, United States

University of Rochester, Rochester, New York, United States

Duke University, Durham, North Carolina, United States

Wake Forest University Health, Winston-Salem, North Carolina, United States

University Hospitals-Case Medical Center, Cleveland, Ohio, United States

University of Pittsburgh, Pittsburgh, Pennsylvania, United States

Vanderbilt, Nashville, Tennessee, United States

University of Texas Southwestern Medical Center, Dallas, Texas, United States

MD Anderson Cancer Center, Houston, Texas, United States

Huntsman Cancer Institute At the University of Utah, Salt Lake City, Utah, United States

Contact Details

Name: Mandeep Kaur, MD

Affiliation: Valeant Pharmaceutical NA

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: